Kinetics of anti‐SARS‐CoV‐2 neutralizing antibodies development after BNT162b2 vaccination in patients with amyloidosis and the impact of therapy - Kastritis - - American Journal of Hematology - Wiley Online Library
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment | Blood Cancer Journal
Organ-specific manifestations of COVID-19 infection | Request PDF
PDF) Successful treatment with lenalidomide dexamethasone for second relapse of a patient with non-secretory multiple myeloma with extramedullary liver plasmacytomas: A case report
Toll-Like Receptor 4 Activation Promotes Multiple Myeloma Cell Growth and Survival Via Suppression of The Endoplasmic Reticulum Stress Factor Chop | Scientific Reports
IJMS | Free Full-Text | Metabolic Disorders in Multiple Myeloma
Ioannis V. Kostopoulos's 56 research works in Engineering and Economics
Cureus | Metachronous Bilateral Testicular Plasmacytoma After an Initial Soft Tissue, Extramedullary Plasmacytoma
ΙΩΑΝΝΗΣ ΓΑΒΡΙΑΤΟΠΟΥΛΟΣ - Θήβα - Διάφορα - 11888.gr
ΓΙΑΝΝΗΣ ΓΑΒΡΙΑΤΟΠΟΥΛΟΣ (συνέντευξη): Οι εταιρείες δεν επιθυμούν μόνον το κέρδος, μετέχουμε των συλλογικών αξιών της κοινωνίας μας! - Γλυκούλι
Pathogenesis of bone disease in multiple myeloma: from bench to bedside – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Correlation plots between the rate of change (RC) in the (%) inhibition... | Download Scientific Diagram